COMPANY
About VitraBio
VitraBio, through its AI-based bio platform
Develops safer and more precise immune solutions
Is a next-generation vaccine and therapeutic specialized company.
We focus on AI-VLP technology
Applicable to various fields such as infectious diseases, chronic diseases, and rare diseases
We are developing personalized bio therapeutic platforms.
Based on technology-driven R&D, global production capabilities, and an ethical approach
We aim to contribute to solving global health issues.
Business Area
We are expanding into various technology-driven healthcare fields.
Advancement of the AI-VLP Platform
The efficiency and applicability of the AI-based vaccine platform
We are conducting continuous research and development to expand them
Production & Supply
Precise vaccine production and global supply
Smart manufacturing
Based on a smart manufacturing system,
rapidly producing high-quality vaccines
We are producing and expanding our supply chain.
Bio Therapeutic Development
Expanding into the fields of immunotherapy and prevention,
we are planning personalized therapeutics for various diseases such as rare diseases, infectious
diseases, and allergies by applying AI-VLP technology.
We present a new standard for next-generation bio vaccines.
VitraBio’s AI-VLP Platform utilizes AI-based design
To rapidly and precisely develop virus-like particles
It is an innovative immune technology platform.
This technology offers greater precision and flexibility than traditional vaccines.
Through vaccines customized according to disease characteristics
It addresses various diseases such as infectious diseases, autoimmune disorders, and cancer
In addition, AI-VLP technology can be applied to drug delivery systems
Contributing to accurate targeting and the development of effective therapeutics
To rapidly and precisely develop virus-like particles
It is an innovative immune technology platform.
This technology offers greater precision and flexibility than traditional vaccines.
Through vaccines customized according to disease characteristics
It addresses various diseases such as infectious diseases, autoimmune disorders, and cancer
In addition, AI-VLP technology can be applied to drug delivery systems
Contributing to accurate targeting and the development of effective therapeutics
